The table below shows TANDEM DIABETES CARE INC's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
$11.05M
-$18.28M
-$8.00M
-$18.33M
$13.80M
$28.68M
Capital expenditure
$6.27M
$2.96M
$4.46M
$8.83M
$2.64M
$3.52M
Investing cash flow
-$195.45M
$9.19M
-$5.06M
-$26.33M
$5.20M
-$6.09M
Dividends paid
-
-
-
-
TNDM operating cash flow (10-K history)
TANDEM DIABETES CARE INC reported operating cash flow of -$9.72M for fiscal year 2025. That is down 140.1% from $24.23M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$61.17M (FY 2016) to -$9.72M. Figures come from the company's audited annual reports as filed with the SEC.
